Advanced Lab Technologies Core (Core I) One of the greatest added values of the Harvard University (HU) CFAR has been accelerated member access to new and emerging technologies. Science is accelerated by changes in technology, and the evolution of flow cytometric, imaging and genomic techniques continues at a rapid pace. However, access to such technologies and associated computational methodologies is an ever increasing and challenging barrier to individual investigators. Acquisition and optimization of instrumentation and softwares and making them accessible remains the primary focus of the HU CFAR Advanced Lab Technologies Core (ALTC). Making these cutting- edge technologies available to HU CFAR users adds critically needed value to their studies of HIV reservoir and cure, virus-host interactions, therapeutic interventions, and vaccine development. The consolidated ALTC offers a unified pipeline of immunology services, molecular biology services, and training opportunities strategically placed to serve the greater Harvard community at the most effective fiscal value. Indeed, the ALTC serves hundreds of HU CFAR users and their global collaborators supported by more than 100 NIH- funded grants/contracts across ten different NIH Institutes and Centers. The ALTC also continues to focus on providing critical individualized technical support to Early Career Investigators (ECI), including dozens of HU CFAR Developmental and Mentoring Core awardees. At the current time, much of the identified need for members is in the capture of information regarding the phenotypic and functional state of individual cells, indexing these samples, and then capitalizing on this precious biomaterial to develop a comprehensive picture of the genomic landscape that exists in particular disease states. To ensure that all Harvard University CFAR laboratories have access to this remarkable analytical power, this core will facilitate access to such technologies through the following aims: 1) Provide HU CFAR member access to state-of-the art instrumentation and techniques. 2) Provide user training in all ALTC technologies, as well as computational assistance. 3) Build a virtual community using state of the art sharing and distribution tools.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI060354-17
Application #
9960409
Study Section
Special Emphasis Panel (ZAI1)
Project Start
2004-07-01
Project End
2024-07-31
Budget Start
2020-08-01
Budget End
2021-07-31
Support Year
17
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Harvard University
Department
Type
DUNS #
082359691
City
Cambridge
State
MA
Country
United States
Zip Code
02138
Mitton, Julian A; North, Crystal M; Muyanja, Daniel et al. (2018) Smoking cessation after engagement in HIV care in rural Uganda. AIDS Care 30:1622-1629
Thomas, Beena E; Subbaraman, Ramnath; Sellappan, Senthil et al. (2018) Pretreatment loss to follow-up of tuberculosis patients in Chennai, India: a cohort study with implications for health systems strengthening. BMC Infect Dis 18:142
O'Cleirigh, Conall; Pantalone, David W; Batchelder, Abigail W et al. (2018) Co-occurring psychosocial problems predict HIV status and increased health care costs and utilization among sexual minority men. J Behav Med 41:450-457
Mayer, Kenneth H (2018) Old Pathogen, New Challenges: A Narrative Review of the Multilevel Drivers of Syphilis Increasing in American Men Who Have Sex With Men. Sex Transm Dis 45:S38-S41
Cheng, Hao D; Grimm, Sebastian K; Gilman, Morgan Sa et al. (2018) Fine epitope signature of antibody neutralization breadth at the HIV-1 envelope CD4-binding site. JCI Insight 3:
Castillo-Mancilla, Jose R; Morrow, Mary; Boum, Yap et al. (2018) Brief Report: Higher ART Adherence Is Associated With Lower Systemic Inflammation in Treatment-Naive Ugandans Who Achieve Virologic Suppression. J Acquir Immune Defic Syndr 77:507-513
Mayer, Kenneth H; Chan, Philip A; R Patel, Rupa et al. (2018) Evolving Models and Ongoing Challenges for HIV Preexposure Prophylaxis Implementation in the United States. J Acquir Immune Defic Syndr 77:119-127
Kirtane, Ameya R; Abouzid, Omar; Minahan, Daniel et al. (2018) Development of an oral once-weekly drug delivery system for HIV antiretroviral therapy. Nat Commun 9:2
Richterman, Aaron; Cheung, Hoi Ching; Meiselbach, Mark K et al. (2018) Risk Factors for Self-Reported Cholera Within HIV-Affected Households in Rural Haiti. Open Forum Infect Dis 5:ofy127
Calabrese, Sarah K; Earnshaw, Valerie A; Krakower, Douglas S et al. (2018) A Closer Look at Racism and Heterosexism in Medical Students' Clinical Decision-Making Related to HIV Pre-Exposure Prophylaxis (PrEP): Implications for PrEP Education. AIDS Behav 22:1122-1138

Showing the most recent 10 out of 1030 publications